$TENX
Market Cap:
$21.48 Million
Financial Snapshot
Revenue
$0.00
TTM
Gross Margin
Net Earnings
$8.109M
TTM
Current Ratio
3895.23%
Q3 2024
Book Value
$97.22M
Q3 2024
P/E
2.648
Nov 29, 2024 EST
Free Cash Flow
Revenues
Revenues
Loading...
Loading...
Revenue YoY Change
Loading...
Loading...
Revenues
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $50.00K | $290.0K | $90.00K | $100.0K | $320.0K | $50.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | -82.76% | 222.22% | -10.0% | -68.75% | 540.0% |
Expenses
Cost Of Revenues
Loading...
Loading...
Gross Profit
Loading...
Loading...
Gross Profit Margin
Loading...
Loading...
Gross Profit
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $50.00K | $290.0K | $90.00K | $100.0K | $320.0K | $50.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost Of Revenue | $0.00 | $0.00 | $0.00 | $130.0K | $40.00K | $50.00K | $220.0K | $40.00K | |||||||||||||||||||||
| Gross Profit | $0.00 | $0.00 | $50.00K | $160.0K | $50.00K | $50.00K | $100.0K | $10.00K | |||||||||||||||||||||
| Gross Profit Margin | 100.0% | 55.17% | 55.56% | 50.0% | 31.25% | 20.0% |
Selling, General & Admin Expense
Loading...
Loading...
Research & Development
Loading...
Loading...
Depreciation, Depletion & Amortization
Loading...
Loading...
SGA Expense to Gross Profit Ratio
Loading...
Loading...
R&D To Gross Profit Ratio
Loading...
Loading...
DDA To Gross Profit Ratio
Loading...
Loading...
Operating Expenses Total
Loading...
Loading...
Operating Profits/Loss
Loading...
Loading...
Operational Expenses
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General & Admin | $5.005M | $5.675M | $7.581M | $5.307M | $5.080M | $5.650M | $5.670M | $6.230M | $3.920M | $7.060M | $13.66M | $3.570M | $5.930M | $7.680M | $7.240M | $7.000M | $1.990M | $1.020M | $1.270M | $1.410M | $1.000M | $840.0K | $2.290M | $1.220M | $690.0K | $670.0K | $1.060M | $1.440M | $1.420M |
| YoY Change | -11.81% | -25.14% | 42.84% | 4.47% | -10.09% | -0.35% | -8.99% | 58.93% | -44.48% | -48.32% | 282.63% | -39.8% | -22.79% | 6.08% | 3.43% | 251.76% | 95.1% | -19.69% | -9.93% | 41.0% | 19.05% | -63.32% | 87.7% | 76.81% | 2.99% | -36.79% | -26.39% | 1.41% | 39.22% |
| % of Gross Profit | 14120.0% | 8537.5% | 7140.0% | 11860.0% | 7680.0% | 72400.0% | |||||||||||||||||||||||
| Research & Development | $3.229M | $5.377M | $25.15M | $4.561M | $3.470M | $1.240M | $3.520M | $13.13M | $6.480M | $6.630M | $2.960M | $2.410M | $2.420M | $2.680M | $2.970M | $1.600M | $940.0K | $750.0K | $1.210M | $1.280M | $1.270M | $1.430M | $1.310M | $780.0K | $220.0K | $170.0K | $200.0K | $460.0K | $920.0K |
| YoY Change | -39.96% | -78.62% | 451.39% | 31.43% | 179.84% | -64.77% | -73.19% | 102.62% | -2.26% | 123.99% | 22.82% | -0.41% | -9.7% | -9.76% | 85.63% | 70.21% | 25.33% | -38.02% | -5.47% | 0.79% | -11.19% | 9.16% | 67.95% | 254.55% | 29.41% | -15.0% | -56.52% | -50.0% | 2.22% |
| % of Gross Profit | 13260.0% | 1850.0% | 4820.0% | 4840.0% | 2680.0% | 29700.0% | |||||||||||||||||||||||
| Depreciation & Amortization | $7.570K | $5.143K | $4.116K | $4.077K | $10.00K | $10.00K | $10.00K | $20.00K | $30.00K | $150.0K | $150.0K | $150.0K | $210.0K | $310.0K | $110.0K | $20.00K | $100.0K | $140.0K | $170.0K | $140.0K | $140.0K | $140.0K | $110.0K | $70.00K | $50.00K | $50.00K | $70.00K | $80.00K | $90.00K |
| YoY Change | 47.19% | 24.95% | 0.96% | -59.23% | 0.0% | 0.0% | -50.0% | -33.33% | -80.0% | 0.0% | 0.0% | -28.57% | -32.26% | 181.82% | 450.0% | -80.0% | -28.57% | -17.65% | 21.43% | 0.0% | 0.0% | 27.27% | 57.14% | 40.0% | 0.0% | -28.57% | -12.5% | -11.11% | 125.0% |
| % of Gross Profit | 300.0% | 93.75% | 300.0% | 420.0% | 310.0% | 1100.0% | |||||||||||||||||||||||
| Operating Expenses | $8.234M | $11.05M | $32.73M | $9.868M | $8.560M | $6.890M | $9.210M | $19.38M | $10.43M | $13.84M | $16.77M | $4.990M | $8.240M | $10.37M | $10.21M | $8.600M | $2.940M | $1.770M | $2.480M | $2.680M | $2.270M | $2.280M | $3.610M | $2.000M | $910.0K | $840.0K | $1.250M | $1.900M | $2.340M |
| YoY Change | -25.5% | -66.23% | 231.66% | 15.28% | 24.24% | -25.19% | -52.48% | 85.81% | -24.64% | -17.47% | 236.07% | -39.44% | -20.54% | 1.57% | 18.72% | 192.52% | 66.1% | -28.63% | -7.46% | 18.06% | -0.44% | -36.84% | 80.5% | 119.78% | 8.33% | -32.8% | -34.21% | -18.8% | 21.88% |
| Operating Profit | $8.234M | -$11.05M | $32.73M | $9.868M | -$19.38M | -$10.43M | -$13.79M | -$16.61M | -$4.940M | -$8.190M | -$10.27M | -$10.20M | |||||||||||||||||
| YoY Change | -174.5% | -133.77% | 231.66% | 85.81% | -24.37% | -16.98% | 236.23% | -39.68% | -20.25% | 0.69% |
Interest Expenses
Loading...
Loading...
Interest Expenses To Operating Income %
Loading...
Loading...
Other Expense/Income
Loading...
Loading...
Interest & Other Expense/Income
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Expense | -$23.97K | $4.443K | -$950.00 | $0.00 | $0.00 | $0.00 | -$50.00K | -$2.210M | -$4.240M | -$7.410M | -$170.0K | -$160.0K | -$24.86M | -$3.610M | -$1.680M | -$1.660M | $0.00 | $0.00 | -$10.00K | $0.00 | -$20.00K | -$20.00K | -$30.00K | -$10.00K | -$10.00K | ||||
| YoY Change | -639.5% | -567.68% | -100.0% | -97.74% | -47.88% | -42.78% | 4258.82% | 6.25% | -99.36% | 588.64% | 114.88% | 1.2% | -100.0% | -100.0% | 0.0% | -33.33% | 200.0% | 0.0% | |||||||||||
| % of Operating Profit | -0.29% | 0.0% | 0.0% | ||||||||||||||||||||||||||
| Other Income/Expense, Net | $547.2K | $9.190K | -$254.8K | $20.00K | $160.0K | $80.00K | $370.0K | $760.0K | $360.0K | $780.0K | -$720.0K | $10.00K | -$80.00K | $290.0K | -$150.0K | $240.0K | $110.0K | $120.0K | $70.00K | $10.00K | $20.00K | $50.00K | $130.0K | $330.0K | $20.00K | $20.00K | $0.00 | $0.00 | $10.00K |
| YoY Change | 5854.73% | -103.61% | -1374.15% | -87.5% | 100.0% | -78.38% | -51.32% | 111.11% | -53.85% | -208.33% | -7300.0% | -112.5% | -127.59% | -293.33% | -162.5% | 118.18% | -8.33% | 71.43% | 600.0% | -50.0% | -60.0% | -61.54% | -60.61% | 1550.0% | 0.0% | -100.0% | -75.0% |
Income/Loss
Pretax Income
Loading...
Loading...
Income Tax
Loading...
Loading...
Net Profits/Loss
Loading...
Loading...
Pretax Income YoY Change
Loading...
Loading...
Income Tax Rate
Loading...
Loading...
Net Profits/Loss YoY Change
Loading...
Loading...
Basic EPS
Loading...
Loading...
Net Income To Revenue Ratio
Loading...
Loading...
Pretax & Net Income
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pretax Income | -$7.711M | -$11.05M | -$32.98M | -$9.850M | -$8.390M | -$6.810M | -$8.840M | -$51.89M | -$10.07M | -$14.08M | -$19.54M | -$9.420M | -$15.71M | -$10.45M | -$10.51M | -$33.22M | -$6.720M | -$3.330M | -$4.070M | -$2.670M | -$2.250M | -$2.230M | -$3.490M | -$1.670M | -$910.0K | -$830.0K | -$1.280M | -$1.910M | -$2.350M |
| YoY Change | -30.21% | -66.51% | 234.86% | 17.4% | 23.2% | -22.96% | -82.96% | 415.29% | -28.48% | -27.94% | 107.43% | -40.04% | 50.33% | -0.57% | -68.36% | 394.35% | 101.8% | -18.18% | 52.43% | 18.67% | 0.9% | -36.1% | 108.98% | 83.52% | 9.64% | -35.16% | -32.98% | -18.72% | 25.0% |
| Income Tax | $0.00 | $0.00 | $0.00 | $0.00 | -$7.960M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| % Of Pretax Income | |||||||||||||||||||||||||||||
| Net Earnings | -$7.711M | -$11.05M | -$32.47M | -$9.851M | -$8.390M | -$6.810M | -$8.840M | -$43.92M | -$10.07M | -$14.08M | -$19.54M | -$9.420M | -$15.71M | -$10.45M | -$10.51M | -$33.22M | -$6.720M | -$3.330M | -$4.070M | -$2.670M | -$2.250M | -$2.230M | -$3.490M | -$1.670M | -$910.0K | -$830.0K | -$1.280M | -$1.910M | -$2.350M |
| YoY Change | -30.21% | -65.98% | 229.64% | 17.42% | 23.2% | -22.96% | -79.87% | 336.15% | -28.48% | -27.94% | 107.43% | -40.04% | 50.33% | -0.57% | -68.36% | 394.35% | 101.8% | -18.18% | 52.43% | 18.67% | 0.9% | -36.1% | 108.98% | 83.52% | 9.64% | -35.16% | -32.98% | -18.72% | 25.0% |
| Net Earnings / Revenue | -28160.0% | -6737.93% | -10466.67% | -15710.0% | -3265.63% | -21020.0% | |||||||||||||||||||||||
| Basic Earnings Per Share | |||||||||||||||||||||||||||||
| Diluted Earnings Per Share | -$31.04 | -$7.51 | -$1.603M | -$1.327M | -$1.353M | -$4.365M | -$6.270M | -$31.15M | -$7.142M | -$10.06M | -$41.57M | -$117.8M | -$261.8M | -$174.2M | -$210.2M | -$1.107B | -$336.0M | -$166.5M | -$203.5M | -$133.5M | -$112.5M | -$223.0M | -$349.0M | -$167.0M | -$91.00M | -$83.00M | -$128.0M | -$191.0M | -$487.2M |
Assets & Liabilities
Cash & Short-Term Investments
Loading...
Loading...
Cash & Equivalents
Loading...
Loading...
Cash To Operating Expenses Ratio
Loading...
Loading...
Inventory
Loading...
Loading...
Receivables
Loading...
Loading...
Total Short-Term Assets
Loading...
Loading...
Property, Plant And Equipment
Loading...
Loading...
Long-Term Investments
Loading...
Loading...
Total Long-Term Assets
Loading...
Loading...
Total Assets
Loading...
Loading...
Net Income To Total Assets Percentage
Loading...
Loading...
Accounts Payable
Loading...
Loading...
Short-Term Debt
Loading...
Loading...
Long Term Debt Due
Loading...
Loading...
Total Short-Term Liabilities
Loading...
Loading...
Long-Term Debt
Loading...
Loading...
Other Long-Term Liabilities
Loading...
Loading...
Total Long-Term Liabilities
Loading...
Loading...
Total Liabilities
Loading...
Loading...
Short-Term To Long-Term Debt Ratio
Loading...
Loading...
Short-Term Assets To Debt Ratio
Loading...
Loading...
Long-Term Debt To Net Income Ratio
Loading...
Loading...
Assets & Liabilities
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Short-Term Investments | $9.792M | $2.124M | $5.584M | $6.710M | $5.400M | $12.86M | $7.730M | $13.28M | $20.19M | $17.13M | $58.32M | $780.0K | $1.880M | $950.0K | $630.0K | $2.560M | $4.880M | $20.00K | $0.00 | $590.0K | $300.0K | $180.0K | $2.440M | $4.250M | $5.470M | $190.0K | $740.0K | $50.00K | $80.00K |
| YoY Change | 361.09% | -61.97% | -16.78% | 24.26% | -58.01% | 66.36% | -41.79% | -34.22% | 17.86% | -70.63% | 7376.92% | -58.51% | 97.89% | 50.79% | -75.39% | -47.54% | 24300.0% | -100.0% | 96.67% | 66.67% | -92.62% | -42.59% | -22.3% | 2778.95% | -74.32% | 1380.0% | -37.5% | ||
| Cash & Equivalents | $9.792M | $2.124M | $5.584M | $6.250M | $4.910M | $12.37M | $1.600M | $10.00M | $3.660M | $7.930M | $58.32M | $780.0K | $1.880M | $950.0K | $630.0K | $2.560M | $4.880M | $20.00K | $0.00 | $590.0K | $300.0K | $180.0K | $2.440M | $4.250M | $5.470M | $190.0K | $740.0K | $50.00K | $80.00K |
| Short-Term Investments | $0.00 | $460.0K | $490.0K | $490.0K | $6.120M | $3.280M | $16.53M | $9.200M | |||||||||||||||||||||
| Other Short-Term Assets | $1.891M | $1.085M | $105.1K | $80.00K | $780.0K | $460.0K | $290.0K | $280.0K | $320.0K | $280.0K | $400.0K | $420.0K | $620.0K | $290.0K | $950.0K | $160.0K | $70.00K | $1.460M | $160.0K | $80.00K | $120.0K | $70.00K | $90.00K | $80.00K | $70.00K | $60.00K | $20.00K | $20.00K | $30.00K |
| YoY Change | 74.35% | 932.35% | 31.35% | -89.74% | 69.57% | 58.62% | 3.57% | -12.5% | 14.29% | -30.0% | -4.76% | -32.26% | 113.79% | -69.47% | 493.75% | 128.57% | -95.21% | 812.5% | 100.0% | -33.33% | 71.43% | -22.22% | 12.5% | 14.29% | 16.67% | 200.0% | 0.0% | -33.33% | |
| Inventory | $0.00 | $30.00K | $180.0K | $100.0K | $80.00K | $260.0K | $540.0K | $0.00 | |||||||||||||||||||||
| Prepaid Expenses | |||||||||||||||||||||||||||||
| Receivables | $0.00 | $50.00K | $70.00K | $50.00K | $80.00K | $40.00K | $450.0K | $10.00K | $140.0K | $70.00K | $30.00K | $0.00 | |||||||||||||||||
| Other Receivables | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $30.00K | $90.00K | $40.00K | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||
| Total Short-Term Assets | $11.68M | $3.208M | $5.689M | $6.800M | $6.180M | $13.32M | $8.060M | $13.63M | $20.56M | $17.51M | $58.97M | $1.840M | $2.630M | $1.630M | $2.180M | $2.750M | $4.950M | $1.480M | $150.0K | $670.0K | $420.0K | $250.0K | $2.530M | $4.360M | $5.940M | $250.0K | $760.0K | $70.00K | $110.0K |
| YoY Change | 264.15% | -43.6% | -16.34% | 10.03% | -53.6% | 65.26% | -40.87% | -33.71% | 17.42% | -70.31% | 3104.89% | -30.04% | 61.35% | -25.23% | -20.73% | -44.44% | 234.46% | 886.67% | -77.61% | 59.52% | 68.0% | -90.12% | -41.97% | -26.6% | 2276.0% | -67.11% | 985.71% | -36.36% | |
| Property, Plant & Equipment | $0.00 | $186.7K | $294.8K | $60.00K | $180.0K | $10.00K | $10.00K | $20.00K | $40.00K | $50.00K | $120.0K | $210.0K | $290.0K | $440.0K | $380.0K | $210.0K | $180.0K | $190.0K | $300.0K | $390.0K | $410.0K | $430.0K | $490.0K | $240.0K | $30.00K | $60.00K | $80.00K | $140.0K | $200.0K |
| YoY Change | -100.0% | -36.67% | 391.33% | -66.67% | 1700.0% | 0.0% | -50.0% | -50.0% | -20.0% | -58.33% | -42.86% | -27.59% | -34.09% | 15.79% | 80.95% | 16.67% | -5.26% | -36.67% | -23.08% | -4.88% | -4.65% | -12.24% | 104.17% | 700.0% | -50.0% | -25.0% | -42.86% | -30.0% | |
| Goodwill | |||||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||||
| Intangibles | |||||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||||
| Long-Term Investments | $0.00 | $1.810M | $8.590M | $18.02M | $30.97M | ||||||||||||||||||||||||
| YoY Change | -100.0% | -78.93% | -52.33% | -41.81% | |||||||||||||||||||||||||
| Other Assets | $1.120K | $9.550K | $8.440K | $10.00K | $10.00K | $10.00K | $10.00K | $1.110M | $1.110M | $1.110M | $70.00K | $210.0K | $340.0K | $150.0K | $50.00K | $200.0K | $5.300M | $0.00 | |||||||||||
| YoY Change | -88.27% | 13.15% | -15.6% | 0.0% | 0.0% | 0.0% | -99.1% | 0.0% | 0.0% | 1485.71% | -66.67% | -38.24% | 126.67% | 200.0% | -75.0% | -96.23% | |||||||||||||
| Total Long-Term Assets | $1.120K | $196.2K | $303.2K | $70.00K | $190.0K | $20.00K | $1.830M | $9.710M | $52.43M | $65.40M | $34.46M | $1.340M | $1.510M | $1.290M | $1.350M | $1.050M | $5.610M | $340.0K | $460.0K | $590.0K | $630.0K | $670.0K | $750.0K | $480.0K | $260.0K | $280.0K | $230.0K | $250.0K | $280.0K |
| YoY Change | -99.43% | -35.29% | 333.2% | -63.16% | 850.0% | -98.91% | -81.15% | -81.48% | -19.83% | 89.79% | 2471.64% | -11.26% | 17.05% | -4.44% | 28.57% | -81.28% | 1550.0% | -26.09% | -22.03% | -6.35% | -5.97% | -10.67% | 56.25% | 84.62% | -7.14% | 21.74% | -8.0% | -10.71% | |
| Total Assets | $11.68M | $3.405M | $5.992M | $6.870M | $6.370M | $13.34M | $9.890M | $23.34M | $72.99M | $82.91M | $93.43M | $3.180M | $4.140M | $2.920M | $3.530M | $3.800M | $10.56M | $1.820M | $610.0K | $1.260M | $1.050M | $920.0K | $3.280M | $4.840M | $6.200M | $530.0K | $990.0K | $320.0K | $390.0K |
| YoY Change | |||||||||||||||||||||||||||||
| Accounts Payable | $2.073M | $448.4K | $859.6K | $760.0K | $1.660M | $750.0K | $610.0K | $730.0K | $970.0K | $1.180M | $410.0K | $980.0K | $540.0K | $890.0K | $500.0K | $200.0K | $170.0K | $480.0K | $150.0K | $270.0K | $240.0K | $10.00K | $40.00K | $90.00K | $210.0K | $310.0K | $340.0K | $320.0K | $280.0K |
| YoY Change | 362.31% | -47.84% | 13.11% | -54.22% | 121.33% | 22.95% | -16.44% | -24.74% | -17.8% | 187.8% | -58.16% | 81.48% | -39.33% | 78.0% | 150.0% | 17.65% | -64.58% | 220.0% | -44.44% | 12.5% | 2300.0% | -75.0% | -55.56% | -57.14% | -32.26% | -8.82% | 6.25% | 14.29% | |
| Accrued Expenses | $1.012M | $775.1K | $704.3K | $1.240M | $870.0K | $820.0K | $360.0K | $5.250M | $3.100M | $2.660M | $730.0K | $690.0K | $1.270M | $1.250M | $840.0K | $240.0K | $50.00K | $100.0K | $80.00K | $40.00K | $60.00K | $0.00 | $30.00K | $80.00K | $90.00K | $100.0K | $120.0K | $190.0K | $430.0K |
| YoY Change | 30.63% | 10.04% | -43.2% | 42.53% | 6.1% | 127.78% | -93.14% | 69.35% | 16.54% | 264.38% | 5.8% | -45.67% | 1.6% | 48.81% | 250.0% | 380.0% | -50.0% | 25.0% | 100.0% | -33.33% | -100.0% | -62.5% | -11.11% | -10.0% | -16.67% | -36.84% | -55.81% | ||
| Deferred Revenue | |||||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||||
| Short-Term Debt | $500.9K | $624.3K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.250M | $0.00 | $60.00K | $40.00K | $40.00K | $1.150M | $20.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $80.00K | $20.00K | $80.00K | $250.0K |
| YoY Change | -19.77% | -100.0% | -100.0% | 50.0% | 0.0% | -96.52% | 5650.0% | -100.0% | 300.0% | -75.0% | -68.0% | ||||||||||||||||||
| Long-Term Debt Due | $0.00 | $120.0K | $0.00 | $100.0K | $350.0K | $60.00K | $60.00K | $40.00K | $0.00 | $130.0K | $180.0K | $0.00 | $0.00 | $110.0K | $180.0K | $50.00K | $100.0K | $60.00K | $20.00K | $20.00K | |||||||||
| YoY Change | -100.0% | -100.0% | -71.43% | 483.33% | 0.0% | 50.0% | -100.0% | -27.78% | -100.0% | -38.89% | 260.0% | -50.0% | 66.67% | 200.0% | 0.0% | ||||||||||||||
| Total Short-Term Liabilities | $3.587M | $1.848M | $1.564M | $2.120M | $2.530M | $1.570M | $1.010M | $6.200M | $4.600M | $4.520M | $2.570M | $1.910M | $3.130M | $2.180M | $1.400M | $480.0K | $270.0K | $1.850M | $430.0K | $310.0K | $290.0K | $10.00K | $180.0K | $340.0K | $350.0K | $580.0K | $530.0K | $600.0K | $980.0K |
| YoY Change | 94.1% | 18.15% | -26.23% | -16.21% | 61.15% | 55.45% | -83.71% | 34.78% | 1.77% | 75.88% | 34.55% | -38.98% | 43.58% | 55.71% | 191.67% | 77.78% | -85.41% | 330.23% | 38.71% | 6.9% | 2800.0% | -94.44% | -47.06% | -2.86% | -39.66% | 9.43% | -11.67% | -38.78% | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $120.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.990M | $1.360M | $4.460M | $0.00 | $230.0K | $540.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $50.00K | $100.0K | $0.00 | $20.00K |
| YoY Change | -100.0% | -100.0% | 119.85% | -69.51% | -100.0% | -57.41% | -100.0% | -50.0% | -100.0% | ||||||||||||||||||||
| Other Long-Term Liabilities | $0.00 | $64.20K | $183.6K | $0.00 | $60.00K | $0.00 | $0.00 | $10.00K | $50.00K | ||||||||||||||||||||
| YoY Change | -100.0% | -65.03% | -100.0% | -100.0% | -80.0% | ||||||||||||||||||||||||
| Total Long-Term Liabilities | $0.00 | $64.20K | $183.6K | $120.0K | $60.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.00K | $3.040M | $1.360M | $4.460M | $0.00 | $230.0K | $540.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $50.00K | $100.0K | $0.00 | $20.00K |
| YoY Change | -100.0% | -65.03% | 52.99% | 100.0% | -100.0% | -99.67% | 123.53% | -69.51% | -100.0% | -57.41% | -100.0% | -50.0% | -100.0% | ||||||||||||||||
| Total Liabilities | $3.587M | $1.912M | $1.748M | $2.240M | $2.590M | $1.570M | $1.010M | $6.200M | $12.56M | $12.48M | $10.54M | $4.960M | $4.490M | $6.650M | $1.400M | $700.0K | $810.0K | $1.850M | $430.0K | $310.0K | $290.0K | $10.00K | $180.0K | $340.0K | $350.0K | $630.0K | $640.0K | $600.0K | $990.0K |
| YoY Change | 87.58% | 9.41% | -21.98% | -13.51% | 64.97% | 55.45% | -83.71% | -50.64% | 0.64% | 18.41% | 112.5% | 10.47% | -32.48% | 375.0% | 100.0% | -13.58% | -56.22% | 330.23% | 38.71% | 6.9% | 2800.0% | -94.44% | -47.06% | -2.86% | -44.44% | -1.56% | 6.67% | -39.39% |
Ownership
Basic Shares Outstanding
Loading...
Loading...
Diluted Shares Outstanding
Loading...
Loading...
Preferred Stock
Loading...
Loading...
Treasury Stock Shares
Loading...
Loading...
Stock Issuance & Repurchase
Loading...
Loading...
Ownership Data
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Basic Shares Outstanding | |||||||||||||||||||||||||||||
| Diluted Shares Outstanding | |||||||||||||||||||||||||||||
| Preferred Stock | |||||||||||||||||||||||||||||
| Treasury Stock Shares |
Return On Shareholders' Equity
Loading...
Loading...
Book Value
Loading...
Loading...
Free Cash Flow
Loading...
Loading...
Free Cash Flow YoY
Loading...
Loading...
Free Cash Flow Margin
Loading...
Loading...
Dividends
Dividends
Loading...
Loading...
Stock Price
Loading...
Market Cap: $21.476 Million
About TENAX THERAPEUTICS, INC.
Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company is headquartered in Chapel Hill, North Carolina and currently employs 5 full-time employees. The firm is focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The firm's products include TNX-201 (oral enteric coated imatinib) and TNX-103 (oral levosimendan). The firm is developing dosing and a formulation of imatinib mesylate, a kinase inhibitor for the treatment of pulmonary arterial hypertension (PAH). The Company’s other programs include TNX-101 (IV), TNX-102 (subcutaneous) and TNX-103 (oral) levosimendan. Levosimendan is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. The firm has completed the Phase II trial of levosimendan in patients with PH and heart failure with preserved ejection fraction (HFpEF).
Industry: Pharmaceutical Preparations Peers: Adhera Therapeutics, Inc. RenovaCare, Inc. U.S. Stem Cell, Inc. Fresh Tracks Therapeutics, Inc. POLARITYTE, INC. LadRx Corp Scopus BioPharma Inc.
